I was reviewing some stats on the most read articles on my blog for the last month.
And because they're so popular, I thought I'd recap the top 5:
– about the publisher, media magnate, composer and
orchestral conductor who arranged songs for Frank Sinatra and produced three
Michael Jackson albums – including Thriller, still the bestselling album ever
recorded by an individual artist. From January 2012.
– with information about developments
that will help researchers and marketers identify patient populations most
likely to respond to their medications. From October 2010.
– excerpted from one of my favorite features of WIRED
magazine, this clearly illustrates that’s it is not what’s inside – but what it
does – that really matters. Here is what's really in 2000 Flushes. See for yourself if this is really what
makes the brand. From November
2008.
– with the list from this parable
using historical personalities and events. It may not be especially
original (and it's not a book you would read for its literary qualities),
but it does offer powerful lessons from the past to inspire today's reader. From February 2010.
– highlighted from the editors of
Pharmaceutical Executive, who believe that what still makes it hard to assess
prospects for biosimilars is the challenge of defining the terms of engagement.
“The concept itself is open to interpretation, which leads to definitional
problems,” they write. “In addition to biosimilars, which are essentially
generic versions of branded off-patent biologics, there are biobetters, which
are conceived to differ from the originator in formulation or delivery mode
with the overall aim of obtaining an improved pharmacokinetic profile. This
leads in turn to a lack of clarity in figuring where the real opportunities are
and defining a strategy to exploit them.”
From October 2010.
Just click on any other the bold titles to go back to the original post.
No comments:
Post a Comment